BNP Paribas Financial Markets’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,535
| Closed | -$14.1K | – | 4128 |
|
|
2021
Q2 | $14.1K | Sell |
1,535
-3,638
| -70% | -$21.2K | ﹤0.01% | 3636 |
|
|
2021
Q1 | $25.7K | Sell |
5,173
-2,774
| -35% | -$13.4K | ﹤0.01% | 3718 |
|
|
2020
Q4 | $34.3K | Sell |
7,947
-1,461
| -16% | -$5.94K | ﹤0.01% | 3707 |
|
|
2020
Q3 | $40.4K | Buy |
9,408
+7,369
| +361% | +$30.8K | ﹤0.01% | 3570 |
|
|
2020
Q2 | $9.15K | Sell |
2,039
-9,365
| -82% | -$41.9K | ﹤0.01% | 3754 |
|
|
2020
Q1 | $45.6K | Buy |
11,404
+6,306
| +124% | +$53.6K | ﹤0.01% | 3582 |
|
|
2019
Q4 | $43.2K | Sell |
5,098
-724
| -12% | -$5.65K | ﹤0.01% | 3718 |
|
|
2019
Q3 | $39.9K | Buy |
5,822
+1,683
| +41% | +$12.3K | ﹤0.01% | 3604 |
|
|
2019
Q2 | $34.5K | Sell |
4,139
-3,379
| -45% | -$29.2K | ﹤0.01% | 3648 |
|
|
2019
Q1 | $68.9K | Buy |
7,518
+7,509
| +83,433% | +$76.3K | ﹤0.01% | 3335 |
|
|
2018
Q4 | $99 | Sell |
9
-1,318
| -99% | -$16.6K | ﹤0.01% | 4182 |
|
|
2018
Q3 | $18.5K | Buy |
1,327
+384
| +41% | +$5.2K | ﹤0.01% | 3441 |
|
|
2018
Q2 | $10K | Sell |
943
-5,364
| -85% | -$52.3K | ﹤0.01% | 3781 |
|
|
2018
Q1 | $54.6K | Sell |
6,307
-1,077
| -15% | -$9.45K | ﹤0.01% | 3518 |
|
|
2017
Q4 | $69.8K | Buy |
7,384
+3,677
| +99% | +$28.7K | ﹤0.01% | 3489 |
|
|
2017
Q3 | $29.1K | Buy |
3,707
+1,500
| +68% | +$11.3K | ﹤0.01% | 3411 |
|
|
2017
Q2 | $19K | Buy |
+2,207
| New | +$15.8K | ﹤0.01% | 3693 |
|
|
2015
Q2 | – | Sell |
-247
| Closed | -$1.76K | – | 3660 |
|
|
2015
Q1 | $1.76K | Buy |
+247
| New | +$1.7K | ﹤0.01% | 3490 |
|
|
2014
Q4 | – | Sell |
-700
| Closed | -$6.47K | – | 3490 |
|
|
2014
Q3 | $6.47K | Buy |
700
+588
| +525% | +$7.95K | ﹤0.01% | 3755 |
|
|
2014
Q2 | $2.09K | Buy |
+112
| New | +$1.9K | ﹤0.01% | 3079 |
|
Other funds holding KIN
BNP Paribas Financial Markets's KIN Position: Q3 2021 in Review
BNP Paribas Financial Markets sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,535 shares — an estimated $14.1K sold.
BNP Paribas Financial Markets first reported a position in KIN in Q2 2014 and held it in 20 quarters. The position peaked at $69.8K in Q4 2017. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- BNP Paribas Financial Markets reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,535 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $14.1K.
- BNP Paribas Financial Markets first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 20 quarters.
- BNP Paribas Financial Markets's Kindred Biosciences, Inc. position peaked at $69.8K in Q4 2017.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.